BioCatalystWatch
MIRMWorkspace / MIRM / OverviewCompany library
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (MIRM)

Website

Price
Market cap
Next catalystExpected 2H 2026Brelovitug — AZURE clinical program · Study completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

IBAT

Upcoming / outlook

  • Timing and evidence

IBAT

Upcoming / outlook

IBAT

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

PDE4D

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Brelovitug

HBsAg

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ATEBRIOZ (zilurgisertib) — PROGRESS Cohort 2

ALK2

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Brelovitug

HBsAg

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

IBAT

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

IBAT

Upcoming / outlook

  • Timing and evidence

ATEBRIOZ (zilurgisertib) — PROGRESS Cohort 2

ALK2

Upcoming / outlook

  • Timing and evidence

IBAT

Upcoming / outlook

PDE4D

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

Approved / commercial

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MIRM PR & News

PR & News

MIRM SEC archive